Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
After the drug’s local license holder called for a brief pause in new patient starts last week, doctors in Japan can once again prescribe Amgen’s rare autoimmune disease med Tavneos (avacopan), alb | After the drug’s local license holder called for a brief pause in new patient starts last week, doctors in Japan can once again prescribe Amgen’s rare autoimmune disease med Tavneos (avacopan), albeit with revised safety precautions tucked into the product packaging.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Amgen stands by Tavneos, despite reports of 20 deaths in Japan

FDA seeks to withdraw avacopan approval over alleged data manipulation, false statements

Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drug

Immunovant’s potential autoimmune ‘blockbuster’; Wave’s RNA editing update

Immunovant shares surge on arthritis trial data

Switzerland monitors Japanese concerns over Tavneos drug

Kissei Ordered to Warn over Vasculitis Drug after Fatalities

EU and US advisers split over AstraZeneca breast cancer drug

New data show VEGF bispecifics could compete with Summit, Akeso drug